2014 – Biz News Today

Bristol-Myers Squibb Receives Accelerated Approval of Opdivo (nivolumab) from the U.S. Food and Drug Administration

On December 22, 2014

Business News

Original Source

Bristol-Myers Squibb Announces U.S. FDA Approval of Opdivo (nivolumab)

On December 22, 2014

Business News

Original Source

Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2014 on January 27

On December 17, 2014

Business News

Original Source

The Sky’s The Limit On Norwegian Escape

On December 16, 2014

Business News

Norwegian Cruise Line’s largest ship ever,Norwegian Escape, will offer theRead More

Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immuno-Oncology Clinical Collaboration Studying Opdivo (nivolumab) and Mogamulizumab in Advanced Solid Tumors

On December 10, 2014

Business News

Original Source

Bristol-Myers Squibb Announces Dividend

On December 9, 2014

Business News

Original Source

Norwegian Cruise Line Unveils 2016/2017 Itineraries

On December 9, 2014

Business News

Norwegian Cruise Line today announced its 2016/2017 deployment. Highlights includeRead More

Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects

On December 8, 2014

Business News

Original Source

Opdivo (nivolumab) Demonstrates High Overall Response Rate of 87% for Treatment of Relapsed or Refractory Hodgkin Lymphoma

On December 6, 2014

Business News

Original Source

Norwegian Cruise Line Sets Sail For Exclusive Partnership With Margaritaville®

On December 5, 2014

Business News

Cruisers should get their Fins Up and shakers of saltRead More

Bristol-Myers Squibb Foundation Awards Nine Grants Totaling More than $3.5 Million to Support Care for High-Risk Patients with Hepatitis B and C in China and India

On December 3, 2014

Business News

Original Source

Bristol-Myers Squibb Foundation Marks World AIDS Day by Awarding $1.47 Million in New Grants to Strengthen HIV-Related Services in Five Sub-Saharan Countries

On December 1, 2014

Business News

Original Source

Bristol-Myers Squibb Receives Complete Response Letter from U.S. Food and Drug Administration for Daclatasvir, an Investigational Treatment for Hepatitis C

On November 26, 2014

Business News

Original Source

Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types

On November 24, 2014

Business News

Original Source

Norwegian Cruise Line Holdings Ltd. Completes Acquisition of Prestige Cruises International, Inc.

On November 19, 2014

Business News

Acquisition grows capacity of the world’s third largest cruiseRead More

Analyses from Phase IIIb Study Provide Additional Data in Earlier Use of Orencia (abatacept) Plus Methotrexate (MTX) in Citrullinated Protein (CCP)-Positive Adult Patients with Early Rheumatoid Arthritis (RA)

On November 17, 2014

Business News

Original Source

Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results from the First Part of the Phase 3 ANNEXA™-A Studies of Investigational Andexanet Alfa with Eliquis (apixaban)

On November 17, 2014

Business News

Original Source

Norwegian Epic to Debut New Entertainment in 2015 for Year-Round European Sailings

On November 17, 2014

Business News

Norwegian Cruise Line today announced a new entertainment line-up forRead More

Study Comparing Opdivo (nivolumab) to Chemotherapy in Treatment Naïve Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor to Demonstrate a Survival Benefit in a Phase 3 Trial

On November 16, 2014

Business News

Original Source

Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland

On November 14, 2014

Business News

Original Source